19 phd-ecotoxicology positions at University Medical Centre Groningen (UMCG) in Netherlands
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
funded by an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description The PhD student will work in close collaboration with collaborators at the University
-
(in Amsterdam and Maastricht regions) are also participating the study. For the CROSSROADS study, we at the UMCG are looking for an enthusiastic researcher. As a PhD student, you will be primarily
-
further develop our understanding of leukemia biology in order to ultimately improve patient care? We currently have a PhD position available at the Department of Hematology in the UMCG, focusing
-
(PhD salary scale) in the final year, based on a full-time appointment. In addition, the UMCG will offer you 8% holiday pay, and 8.3% end-of-year bonus. The conditions of employment comply with
-
team player. Additional Information Benefits A full-time PhD contract for 4 years and an excellent environment for further development. First, a temporary one-year position will be offered with
-
highly desirable - Experience handling large databases - Knowledge of developing and debugging in Java/Python/R. - Knowledge of immunology Additional Information Benefits The PhD student position is for a
-
of research and education. We do this at two locations: UMCG Groningen and Beatrixoord location in Haren. Patient satisfaction, quality, professionalism, and collegiality are highly valued by us. The PhD
-
that do not resemble the nature of the tissue surrounding it, such as a cardiovascular stent. This PhD project will design, synthesize, and operate a new multi-responsive soft miniaturized robot/device
-
funded by an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description We are seeking a highly motivated PhD candidate to join our interdisciplinary team
-
of patients included in the registries. Within the present PhD project you will address further personalization on predictability of disease course and responsiveness to treatments, including ASBTi, in